: The company maintains a "cannabis debt-free" balance sheet with $154.4 million in cash as of December 31, 2025.
Professional outlooks on ACB are mixed, balancing its medical leadership against broader sector risks. buy acb stock
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? : The company maintains a "cannabis debt-free" balance